(Q48004733)

7 February 2018

title

The PEG-switch assay: a fast semi-quantitative method to determine protein reversible cysteine oxidation (English)

1 reference

7 February 2018

author

Joseph Burgoyne

series ordinal

1

1 reference

7 February 2018

author name string

Olujimi Oviosu

series ordinal

2

1 reference

7 February 2018

Philip Eaton

series ordinal

3

1 reference

7 February 2018

publication date

12 July 2013

1 reference

7 February 2018

Journal of Pharmacological and Toxicological Methods

published in

1 reference

7 February 2018

volume

68

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

297-301

1 reference

7 February 2018

Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

Contemporary techniques for detecting and identifying proteins susceptible to reversible thiol oxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

Cysteine redox sensor in PKGIa enables oxidant-induced activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

Redox signaling in cardiac physiology and pathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

The novel nitric oxide synthase inhibitor 4-amino-tetrahydro-L-biopterine prevents brain edema formation and intracranial hypertension following traumatic brain injury in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.07.001

10.1016/J.VASCN.2013.07.001

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018